iTeos Therapeutics所有資訊

iTeos Therapeutics | 4：持股變動聲明-高管 Feltquate David

12/06 18:05 (美東)

iTeos Therapeutics | SC 13G：超過5%持股股東披露文件-BVF Partners L.P.(6.4%),BVF Inc.(6.4%)等

11/21 20:29 (美東)

iTeos Therapeutics | 4：持股變動聲明-高管 Gall Matthew

11/19 20:01 (美東)

iTeos Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Aaron I. Davis(2.8%),Boxer Capital Management, LLC(2.6%)

11/18 21:59 (美東)

iTeos Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Aaron I. Davis(2.8%),Boxer Capital Management, LLC(2.6%)

11/18 10:01 (美東)

iTeos Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-EcoR1 Capital, LLC(4.4%),Oleg Nodelman(4.4%)等

11/14 18:06 (美東)

iTeos Therapeutics | 10-Q：2024財年三季報

11/12 09:30 (美東)

iTeos Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(10.6%)

11/08 14:23 (美東)

iTeos Therapeutics | 8-K：重大事件

11/04 07:04 (美東)

iTeos Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(10.6%)

10/21 16:18 (美東)

iTeos Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Aaron I. Davis(8.1%),Boxer Capital Management, LLC(7.9%)等

10/15 21:50 (美東)

iTeos Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Boxer Asset Management Inc.(0%),Joe Lewis(0%)

10/15 19:24 (美東)

iTeos Therapeutics | SC 13G：超過5%持股股東披露文件-Tang Capital Management, LLC(6.6%),Kevin Tang(6.6%)等

09/30 09:03 (美東)

iTeos Therapeutics | 8-K：重大事件

09/16 07:01 (美東)

iTeos Therapeutics | 4：持股變動聲明-高管 Detheux Michel

08/09 20:03 (美東)

iTeos Therapeutics | 10-Q：2024財年二季報

08/08 07:14 (美東)

iTeos Therapeutics | 4：持股變動聲明-高管 Feltquate David

08/05 07:23 (美東)

iTeos Therapeutics | 3：首次持股聲明-高管 Feltquate David

08/05 07:23 (美東)

iTeos Therapeutics | 4：持股變動聲明-董事 Van Hauwermeiren Timothy

06/13 20:05 (美東)

iTeos Therapeutics | 4：持股變動聲明-董事 Ho Tony W

06/13 20:05 (美東)